<PAGE>
OMB APPROVAL
OMB Number 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form........14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
NEUROMEDICAL SYSTEMS, INC.
------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
------------------------------------------------------------------------------
(Title of Class of Securities)
64124 H 10 9
--------------------------------
(CUSIP Number)
Harry Edelson
300 Tice Boulevard
Woodcliff Lake, New Jersey 07675
------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
June 7, 1999
--------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-l(b)(3) or (4), check the following box [X].
Check the following box if a fee is being paid with the statement [ ]. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-l(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
CUSIP No. 64124 H 10 9 Page 2 of 7 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
EDELSON TECHNOLOGY PARTNERS II, L.P.
TAX ID#22-2848790
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
1,466,000 shares owned of record (b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS, 2(d) or 2(e) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DE
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
----------------------------------------------------------
NUMBER OF SHARED VOTING POWER
SHARES 8 1,466,000 shares
BENEFICIALLY ----------------------------------------------------------
OWNED BY 9 SOLE DISPOSITIVE POWER
EACH REPORTING ----------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 1,466,000 shares
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,466,000 shares
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.7%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS l-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
SCHEDULE 13D
CUSIP No. 64124 H 10 9 Page 3 of 7 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
EDELSON TECHNOLOGY ASSOCIATES II, L.P.
TAX ID#22-2870457
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
1,466,000 shares owned of record (b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS, 2(d) or 2(e) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DE
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
----------------------------------------------------------
NUMBER OF SHARED VOTING POWER
SHARES 8 1,466,000 shares
BENEFICIALLY ----------------------------------------------------------
OWNED BY 9 SOLE DISPOSITIVE POWER
EACH REPORTING ----------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 1,46,000 shares
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,466,000 shares
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.7%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS l-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
SCHEDULE 13D
CUSIP No. 64124 H 10 9 Page 4 of 7 Pages
- --------------------------------------------------------------------------------
l NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
EDELSON TECHNOLOGY PARTNERS III, L.P.
TAX ID#22-3256000
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
0 shares owned of record
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DE
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES ---------------------------------------------------------------
BENEFICIALLY
OWNED BY 8 SHARED VOTING POWER
EACH 0 shares
REPORTING ---------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0 shares
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
SCHEDULE 13D
CUSIP No. 64124 H 10 9 Page 5 of 7 Pages
- --------------------------------------------------------------------------------
l NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
EDELSON TECHNOLOGY ASSOCIATES III, L.P.
TAX ID#22-3257334
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
0 shares owned of record
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DE
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES ---------------------------------------------------------------
BENEFICIALLY
OWNED BY 8 SHARED VOTING POWER
EACH 0 shares
REPORTING ---------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0 shares
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
Page 6 of 7 Pages
This Statement constitutes an amendment to the Statement on Schedule 13G
(the "Original Statement") filed by Edelson Technology Partners II, L.P., a
Delaware limited partnership ("Partnership II"), with respect to shares of
Common Stock, $.001 par value (the "Common Stock"), of Neuromedical Systems,
Inc. Since the filing of the Original Statement, Partnership II purchased
281,000 shares of Common Stock at an average cost of $7.64 per share and sold
193,815 shares of Common Stock at $.035 per share. Edelson Technology Partners
III, L.P., a Delaware limited partnership ("Partnership III"), purchased 100,000
shares of Common Stock at an average cost of $1.37 per share and sold 315,400
shares of Common Stock averaging $.45 per share. Accordingly, the following
items of the Original Statement is amended to read in its entirety as follows:
Item 3. Source and Amount of Funds or Other Consideration. The aggregate
amount of funds required by Partnership II to purchase the aggregate of 281,000
shares of Common Stock reported herein was $2,147,045. The aggregate amount of
funds required by Partnership III to purchase the aggregate of 100,000 shares
of Common Stock reported herein was $137,100. All of the funds used by
Partnership II and III to purchase the Securities were provided from partnership
funds. It is expected that the source of funds to be used by Partnership II and
III for the purchase, if any, of shares of Common Stock and/or Warrants
subsequent to the date hereof will be partnership funds. No part of the purchase
price is or will be represented by borrowings.
Item 5. Interest in Securities of the Issuer.
a) As of the date hereof, the aggregate number of shares of Common Stock
owned beneficially by Partnership II and Associates II is 1,466,000 shares.
This constitutes approximately 4.7% of the issued and outstanding shares of
Common Stock of the Company. The aggregate number of shares owned by
Partnership III and Associates III is zero. The foregoing calculation of
percentage ownership is based upon information as to the issued and
outstanding shares of Common Stock of the Company as of December 31, 1998
furnished by the Company. Except for the Securities, insofar as is known to
Partnership II and III and Associates II and III, none of the persons named
or referred to in response to Item 2 owns any shares of Common Stock or
Warrants.
b) Partnership II and Associates II have shared voting, investment and
disposition power as to the Securities.
c) Partnership II and Associates II sold a total of 193,815 shares of
Common Stock at an average price of $.035 per share through the NASDAQ
exchange. Partnership III and Associates III sold a total of 315,400
shares of Common Stock at an average price of $.45 per share through the
NASDAQ exchange.
d) Not applicable.
<PAGE>
Page 7 of 7 Pages
e) Not applicable.
Item 8. Identification and Classification of Members of a Group. As of this
date hereof, the aggregate number of shares of Common Stock owned
beneficially by Partnership II is 1,466,000 shares, which constitutes
approximately 4.7% of the issued and outstanding shares of Common Stock of
the Company as reported by the company as of December 31, 1998. The
aggregate number of shares of Common Stock owned by Partnership III is zero
shares.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
EDELSON TECHNOLOGY ASSOCIATES II, L.P.
EDELSON TECHNOLOGY PARTNERS II, L.P.
EDELSON TECHNOLOGY ASSOCIATES III, L.P.
EDELSON TECHNOLOGY PARTNERS III, L.P.
DATED: June 9, 1999
-------------
BY: HARRY EDELSON
-------------------
HARRY EDELSON
GENERAL PARTNER
